Holland Capital has sold Quantib to RadNet
Quantib B.V., a portfolio company of Holland Capital, has been sold to RadNet, Inc.
Founded in 2012 and headquartered in the Netherlands, Quantib is a leading radiology artificial intelligence and machine learning company focusing on clinical solutions for prostate cancer and neurodegeneration.
RadNet is a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 350 owned and operated outpatient imaging centers in the USA.
Holland Capital is one of the first independent private equity firms in the Netherlands. Since 1981, they have been successfully and responsibly investing in promising small and medium-sized Dutch businesses with growth ambitions. With a clear investment strategy, they anticipate long-term trends in attractive growth markets, focusing on the healthcare and technology sectors. Their experienced and dedicated investment team knows what entrepreneurship is.
One of Oaklins’ teams in the USA served as the exclusive financial advisor to Quantib B.V.
Talk to the deal team
James McLaren
Oaklins TM Capital
Michael S. Goldman
Oaklins TM Capital
Michael L. Bauman
Oaklins TM Capital
Harrison P. Boeschenstein
Oaklins TM Capital
Related deals
Amber-Allen Publishing has sold its publishing assets to Penguin Publishing Group
Amber-Allen Publishing, home to some of the world’s most influential personal development books, most notably “The Four Agreements” by Don Miguel Ruiz and Janet Mills, has sold its publishing assets to Penguin Publishing Group. When the acquisition is complete, the Amber-Allen list will be managed by the TarcherPerigee imprint.
Learn moreJeco Energies has sold a significant minority interest to NPM Capital
NPM Capital has acquired a significant minority interest in Jeco Energies. By teaming up with NPM Capital, Jeco Energies is ready for the next step in its remarkable growth trajectory and strengthening its position as the leading industrial energy solutions provider.
Learn moreVivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
Learn more